2026 NPPES data Surgery Physician NPI 1124198742 MD
Verify on CMS →

MARK STECKEL, MD

Surgery Physician in FAIRFIELD, Connecticut. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
644
Medicare Part D claims · 151 beneficiaries · Surgery Physician avg: 169
Generic prescribing
73%
generic claims · 27% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$121.59
2 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MARK STECKEL, MD filed 644 Medicare Part D claims in 2023 as a Surgery Physician in FAIRFIELD, Connecticut, prescribing 73% generic.

644
Part D claims, 2023
73%
generic prescribing
$121.59
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARK STECKEL, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

644 Top 31% higher than 69% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). This entry sits in this band. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

MARK STECKEL, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MARK STECKEL, MD?

Quality data not reported

NPI registry status

Active

Issued 11/09/2006

NPI 1124198742

Primary specialty

Surgery Physician

Mid-sized

36,191 US NPIs in this specialty

Medicare Part D claims

644 281% vs specialty avg

2023 prescription claims

Specialty avg: 169

Specialty distribution in Connecticut

How Surgery Physician compares to other specialties among Connecticut providers

Connecticut providers

Surgery Physician share within Connecticut

1. Surgery Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Surgery Physician share within Connecticut

Specialty board-certification context

Estimated specialty board-certified rate — Surgery Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Surgery Physician ABMS/AOA estimate

Est. board-certified rate (Surgery Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Surgery Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK STECKEL, MD appears in the CMS NPPES registry as a Surgery Physician provider holding MD credentials at 140 SHERMAN STREET, FAIRFIELD, CT, 06824, with a listed phone of (203) 256-1320. NPI 1124198742 was issued on 11/09/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what STECKEL most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 644 prescription claims written by this provider, covering 151 Medicare beneficiaries and totaling roughly $70K in drug spend, split 27% brand-name and 73% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Surgery Physician is a mid-sized specialty nationwide, with 36,191 enrolled providers across 56 states and an average of 169 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

140 SHERMAN STREET
FAIRFIELD, CT 06824

Provider Details

NPI 1124198742
Specialty Surgery Physician
Credentials MD
Gender Male
NPI Issued 11/09/2006

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK STECKEL, MD. Source: openpaymentsdata.cms.gov.

Total received

$122

Largest payer

CooperVision Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Above average

MARK STECKEL, MD — brand share 27.0%
Specialty average (est.)

27% brand-name claims vs 73% generic, on 644 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

644
Total Claims
$70K
Total Drug Cost
151
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,041
Total Day Supply
28,692
Brand vs Generic
27% brand / 73% generic
Brand Drug Cost
$54K
Generic Drug Cost
$15K

Patient Demographics

Average Patient Age
74.8 years
Avg HCC Risk Score
1.16
Gender Split
58% female / 42% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MARK STECKEL, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Latanoprost
229
Timolol Maleate
96
Neomycin-Polymyxin-Dexameth
Neomycin/Polymyxin B/Dexametha
88
Lumigan
Bimatoprost
61
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
37
Erythromycin
Erythromycin Base
18
Brimonidine Tartrate
16
Brimonidine Tartrate-Timolol
Brimonidine Tartrate/Timolol
16
Combigan
Brimonidine Tartrate/Timolol
15
Vyzulta
Latanoprostene Bunod
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Surgery Physician Overview

How MARK STECKEL, MD fits within the Surgery Physician landscape nationally.

36,191
Surgery Physician Providers in US
56
States with Surgery Physician
169
Avg Claims per Provider

MARK STECKEL, MD's 644 claims are above the specialty average of 169.

Nearby Surgery Physician Providers in Connecticut

Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as STECKEL.

Compare Surgery Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK STECKEL, MD's specialty?
MARK STECKEL, MD specializes in Surgery Physician and practices in FAIRFIELD, Connecticut. Credentials: MD.
How much does MARK STECKEL, MD prescribe under Medicare Part D?
In 2023, MARK STECKEL, MD wrote 644 Medicare Part D claims totaling $70K in drug costs for 151 beneficiaries.
Where is MARK STECKEL, MD located?
MARK STECKEL, MD is located at 140 SHERMAN STREET, FAIRFIELD, CT, 06824. Phone: (203) 256-1320.
What is MARK STECKEL, MD's NPI number?
MARK STECKEL, MD's National Provider Identifier (NPI) is 1124198742, issued on 11/09/2006.
Does MARK STECKEL, MD prescribe more brand-name or generic drugs?
MARK STECKEL, MD's prescribing is 27% brand-name and 73% generic drugs by claim count, with $54K in brand drug costs.
How many Surgery Physician providers are there in the US?
There are 36,191 Surgery Physician providers across 56 states in the US. The average Surgery Physician provider writes 169 Medicare Part D claims per year.
What drugs does MARK STECKEL, MD prescribe most often?
Based on 2023 Medicare Part D data, MARK STECKEL, MD's most frequently prescribed drugs include Latanoprost, Timolol Maleate, Neomycin-Polymyxin-Dexameth. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK STECKEL, MD accept Medicare?
MARK STECKEL, MD appears in CMS Medicare data with 644 Part D claims and 151 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK STECKEL, MD's credentials?
MARK STECKEL, MD's NPI is 1124198742 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology